跳至主要内容
临床试验/NCT04159181
NCT04159181Unknown不适用

Investigations of the Endocrine Colon in Healthy Individuals

University of Copenhagen4 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年7月16日最近更新:
适应症

试验速览

阶段
不适用
入组人数
10
试验地点
4
主要终点
GLP-1

研究概览

简要总结

This study will examine the role of the colon as an endocrine organ with a focus on the secretion of gastrointestinal peptides.

详细描述

This study will examine the role of the colon as an endocrine organ with a focus on the secretion of gastrointestinal peptides.

We aim to determine the contribution of the colon to the fasting and postprandial release of gut peptides such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Young healthy men will be examined on three occasions at a clinical research Facility after an overnight fast. On one occasion the colon will also be emptied using a cathartic (picoprep). On two occasions an oral solution of lactulose will be administered to stimulate fermentation by colonic bacteria.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy young men (self-reported)
  • BMI between 18,5-24,9 kg/m^2

排除标准

  • Diabetes mellitus (elevated fasting plasma glucose or HbA1c)
  • Family history of diabetes mellitus
  • Intestinal disease (e.g. inflammatory bowel disease, malabsorption)
  • Family history of intestinal diseases
  • Previous gastrointestinal surgery
  • BMI >25 kg/m^2
  • Tobacco use
  • Alcohol consumption > 14 standard drinks/week
  • Kidney, Heart- or Liver disease
  • Treatment with prescription drugs that can not be held for 12h
  • Constipation
  • Accelerated or delayed gastric emptying
  • Absence of daily bowel movements
  • Vegetarian lifestyle
  • > than 3kgs weightloss or weight gain within 3 months
  • Haemoglobin concentration < 8,0mmol/L
  • Bleeding diathesis
  • Latex or bandaid allergies

结局指标

主要结局

GLP-1

时间窗: -60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min

Plasma concentrations of glucagon-like peptide-1 (GLP-1)

次要结局

  • PYY(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)
  • Ghrelin(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)
  • Glucagon(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)
  • Motilin(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)
  • Hydrogen breath test(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)
  • Neurotensin(-60, -45, -30, -15, 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 270. 285, 300 min)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Simon Veedfald

Investigator

University of Copenhagen

研究点 (4)

Loading locations...

相似试验